American Association for Clinical Chemistry
Better health through laboratory medicine
2000 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

11/28/00 AACC and other laboratory groups write to HHS Secretary requesting her assistance in ensuring that CLIA program decisions are coordinated by government agencies.
   
10/12/00 AACC provides comments to the FDA regarding the Agency's new informed consent requirements for using "excess specimens."
   
10/11/00 AACC writes to HHS Secretary Shalala supporting CLIAC's right to comment on proposed changes to the CLIA test categorization process.
   
08/14/00 AACC provides comments to the FDA on the CLIA waiver criteria
   
07/17/00 AACC submits comments to HCFA regarding Medicare coverage criteria for laboratory tests and other items and services
   
06/22/00 AACC submits comments to CDC regarding CLIA regulation of genetic testing
   
05/22/00 AACC submits comments to SACGT regarding additional federal oversight of genetic testing
   
03/09/00 AACC wrote to House and Senate leaders opposing the President's proposed cuts in laboratory reimbursement
   
01/27/00 AACC submitted comments to the Secretary's Advisory Committee on Genetic Testing regarding federal oversight of genetic testing
   
01/20/00 AACC submitts comments to IOM study panel on clinical laboratory reimbursement